Evofem Biosciences Says Pharma 1 Applies For Marketing Approval Of PHEXXI In UAE
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 23 2025
0mins
Source: NASDAQ.COM
Evofem Biosciences' Product Approval: Pharma 1 Drug Store LLC has applied to the UAE Ministry of Health for approval to sell PHEXXI, a hormone-free contraceptive gel by Evofem, which is already FDA-approved in the U.S.
Commercialization Plans: Pharma 1 aims to launch PHEXXI in the UAE by the first quarter of 2026 and holds exclusive rights to commercialize the product in several Middle Eastern countries.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
